Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Radiology|March 10, 2012
Gliomas: diffusion kurtosis MR imaging in gradingSofie Van Cauter, Jelle Veraart, Jan Sijbers, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 24, 2016
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administrationMatthias Van Woensel, Nathalie Wauthoz, Rémi Rosière, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2012
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trialHilko Ardon, Stefaan W Van Gool, Tina Verschuere, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 27, 2012
Reproducibility of rapid short echo time CSI at 3 tesla for clinical applicationsSofie Van Cauter, Diana M Sima, Jan Luts, et al.
Stem Cells (Dayton, Ohio)|March 25, 2011
Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditionsValerie D Roobrouck, Carlos Clavel, Sandra A Jacobs, et al.
Neuro-Oncology|November 1, 2020
DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survivalJoost Dejaegher, Lien Solie, Zoé Hunin, et al.
Scientific Reports|April 29, 2017
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategyMatthias Van Woensel, Thomas Mathivet, Nathalie Wauthoz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiformeSteven De Vleeschouwer, Steffen Fieuws, Stefan Rutkowski, et al.
Anticancer Research|March 27, 2026
Analysis of Clinical Benefit Using DNG64-<i>CAR-V</i> Chimeric Tumor Targeted Amphotropic RNA Vector in <i>CCNG1</i> Expressing CancersSant P Chawla, Samantha Jeffrey, Skyler S Pang, et al.
The Lancet. Oncology|August 14, 2018
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour GroupStefan Rutkowski, Piergiorgio Modena, Daniel Williamson, et al.
Pageof 8